Inozyme Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	217.59	44.47	1.64	7.57	1
Cash & Short-Term Investments	217.59	44.47	1.64	7.57	1
Cash Growth	389.29%	2611.59%	-78.33%	656.80%	-
Accounts Receivable	409.1	189.02	71.48	9.22	-
Other Receivables	-	0.02	0.24	2.33	-
Receivables	409.1	189.04	71.73	11.55	-
Inventory	2,099	921.01	514.39	119.8	-
Prepaid Expenses	-	14.27	9.93	0.22	-
Other Current Assets	431.12	668.16	88.18	97.06	-
Total Current Assets	3,157	1,837	685.86	236.19	1
Property, Plant & Equipment	185.25	12.24	12.47	0.42	-
Long-Term Investments	1	-	-	-	-
Other Intangible Assets	1.55	0.15	0.05	-	-
Long-Term Deferred Tax Assets	3.35	1.53	0.88	0.11	-
Other Long-Term Assets	6.92	7.64	1	-	-
Total Assets	3,355	1,858	700.25	236.72	1
Accounts Payable	420.3	146.37	248.37	158.54	-
Accrued Expenses	12.85	36.37	22.58	15.81	0.24
Short-Term Debt	-	639.39	142.88	3.5	-
Current Portion of Long-Term Debt	1,207	104.53	9.24	-	-
Current Income Taxes Payable	-	5.1	-	7.42	-
Other Current Liabilities	151.69	22.92	82.14	20.29	-
Total Current Liabilities	1,792	954.67	505.21	205.56	0.24
Long-Term Debt	1.87	3.53	56.32	8.68	-
Other Long-Term Liabilities	-	-	-0	-	-
Total Liabilities	1,795	959.13	562.13	214.61	0.24
Common Stock	217.68	209.68	1.13	1	1
Additional Paid-In Capital	-	427.92	36.17	-	-
Retained Earnings	-	261.77	100.82	21.11	-0.24
Comprehensive Income & Other	1,342	-	-	-	-
Shareholders' Equity	1,560	899.37	138.13	22.11	0.76
Total Liabilities & Equity	3,355	1,858	700.25	236.72	1
Total Debt	1,209	747.44	208.44	12.18	-
Net Cash (Debt)	-991.35	-702.97	-206.8	-4.61	1
Net Cash Per Share	-4.62	-3.88	-1.78	-0.04	0.04
Filing Date Shares Outstanding	217.34	209.68	154.49	111	111
Total Common Shares Outstanding	217.34	209.68	154.49	111	111
Working Capital	1,365	882.27	180.65	30.64	0.76
Book Value Per Share	7.18	4.29	0.89	0.20	0.01
Tangible Book Value	1,559	899.22	138.08	22.11	0.76
Tangible Book Value Per Share	7.17	4.29	0.89	0.20	0.01
Machinery	-	20.39	17.03	0.62	-
Construction In Progress	-	1.54	0.16	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.